SelectBIO Liquid Biopsies 2024 focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA), Extracellular Vesicles (Exosomes) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers.  There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.

The conference further explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for early disease screening, patient monitoring and minimal residual disease detection.

This conference is held concurrently with the Innovations in Microfluidics 2024 Conference enabling delegates full access to the scientific presentations in both conferences, co-located exhibit hall, and extensive networking opportunities.

Professor Sunitha Nagrath, Professor at the University of Michigan-Ann Arbor is serving as Conference Chairperson of Liquid Biopsies 2024 Conference